Bloodless glucose monitor to enter trials this year
This article was originally published in Clinica
Executive Summary
Clinical trials are due to begin later this year of a novel glucose monitoring product that its developer, MicroSense International, claims will combine the best features available in conventional finger-stick based methods with a cost-competitive, painless and blood-free system. MicroSense, a St Louis, Missouri-based privately held development stage company, believes that by eliminating the discomfort associated with blood glucose monitoring, patients will gain greater control over their insulin management and an associated decline in complications.